May 2003
Volume 44, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2003
Peritoneal Exudate Cells Cultured with Calcitonin Gene-Related Peptide can Suppress Murine Experimental Autoimmune Uveoretinitis via IL-10
Author Affiliations & Notes
  • T. Kezuka
    Department of Ophthalmology, Hachioji Medical Center, Tokyo Medical University, Hachioji-city, Tokyo, Japan
  • H. Keino
    Department of Ophthalmology, Tokyo Medical University, Tokyo, Japan
  • M. Takeuchi
    Department of Ophthalmology, Tokyo Medical University, Tokyo, Japan
  • N. Yamakawa
    Department of Ophthalmology, Tokyo Medical University, Tokyo, Japan
  • M. Usui
    Department of Ophthalmology, Tokyo Medical University, Tokyo, Japan
  • Footnotes
    Commercial Relationships  T. Kezuka, None; H. Keino, None; M. Takeuchi, None; N. Yamakawa, None; M. Usui, None.
Investigative Ophthalmology & Visual Science May 2003, Vol.44, 4588. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      T. Kezuka, H. Keino, M. Takeuchi, N. Yamakawa, M. Usui; Peritoneal Exudate Cells Cultured with Calcitonin Gene-Related Peptide can Suppress Murine Experimental Autoimmune Uveoretinitis via IL-10 . Invest. Ophthalmol. Vis. Sci. 2003;44(13):4588.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Abstract: : Purpose: To investigate the role of the suppression in murine experimental autoimmune uveoretinitis (EAU) by peritoneal exudate cells (PEC) cultured with calcitonin gene-related peptide (CGRP). Methods: PEC derived from C57BL/6 mice were cultured with CGRP and residues 1-20 of human interphotoreceptor retinoid binding protein (IRBP). EAU was induced by immunization with residues 1-20 of IRBP in Freund’s adjuvant and pertussis toxin in C57BL/6 mice. At the same time, IRBP-peptide immunized mice were injected the PEC cultured with CGRP and IRBP-peptide intravenously. On day 19 after immunization, peptide-specific delayed hypersensitivity (DH) were measured. On day 21 after immunization, animals were sacrificed, and assess the extent of EAU pathologically. Some studies were injected anti-IL-10 antibody into EAU mice treated with CGRP-cultured PEC intraperitonealy, or used IL-10 KO mice as source of PEC. Results: EAU and antigen-specific DH was suppressed by injection of PEC cultured with CGRP (100ng/ml) and human IRBP-peptide. However, human IRBP-peptide mediated EAU was not suppressed by injection of PEC cultured with CGRP and BSA. Furthermore, EAU and antigen-specific DH was not suppressed by injection of PEC cultured with CGRP and IRBP-peptide when mice were injected anti-IL-10 antibody intraperitonealy, or by injection of IL-10 KO mice derived PEC cultured with CGRP and IRBP-peptide. Conclusions: PEC cultured with CGRP could suppress murine EAU in an antigen-specific manner, and IL-10 secreted from PEC might play an important role on the CGRP mediated suppression of murine EAU.

Keywords: uveitis-clinical/animal model • immunomodulation/immunoregulation • immune tolerance/privilege 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×